Literature DB >> 33263822

Early predictors for late hospitalizations up to 14 years after first episode psychosis.

Pontus Strålin1, Maria Skott2, Johan Cullberg3.   

Abstract

PURPOSE: New hospitalizations after first episode psychosis (FEP) may be viewed as an indicator of instability in a psychotic disorder. In the current study we wanted to analyse long term risk for psychosis hospitalizations after FEP. We also wanted to analyse predictors for late hospitalizations, with focus on early antipsychotic medication.
METHODS: First episode psychosis cases were recruited to the Swedish Parachute project in 1996-1997. The program offered highly available and continuous psychosocial support and a cautious use of antipsychotic medication for 5 years from inclusion. Longitudinal data from population registers on psychiatric hospitalizations up to 14 years after inclusion were analysed. One hundred and sixty-one cases were included of the original 175 in the project. Associations with possible early predictive factors from the original project data were analysed with COX regression.
RESULTS: A majority of the cases (67%) had hospitalizations in the first year after inclusion in the study. The cohort then diverged into a group (46%) with new hospitalizations for psychosis after the first year, most of them multiple times, and another group (54%) without new hospitalizations for psychosis, many without any late antipsychotic medication. Forty-two percentage of the cases had antipsychotic medication by month 12, and it was significantly associated with later psychosis hospitalizations (HR = 2.5, p value < 0.001).
CONCLUSIONS: The study demonstrates that a large part of FEP cases have a good outcome as measured by absence of new hospitalizations for psychosis, and that many cases may terminate antipsychotic medication within a year of FEP onset without later relapses needing hospitalizations.
© 2020. The Author(s).

Entities:  

Keywords:  Antipsychotic medication; Early intervention; Psychosis; Relapses; Schizophrenia

Year:  2020        PMID: 33263822     DOI: 10.1007/s00127-020-01991-w

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  34 in total

1.  Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome.

Authors:  Wenche Ten Velden Hegelstad; Tor K Larsen; Bjørn Auestad; Julie Evensen; Ulrik Haahr; Inge Joa; Jan O Johannesen; Johannes Langeveld; Ingrid Melle; Stein Opjordsmoen; Jan Ivar Rossberg; Bjørn Rishovd Rund; Erik Simonsen; Kjetil Sundet; Per Vaglum; Svein Friis; Thomas McGlashan
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

Review 2.  A systematic review and meta-analysis of recovery in schizophrenia.

Authors:  Erika Jääskeläinen; Pauliina Juola; Noora Hirvonen; John J McGrath; Sukanta Saha; Matti Isohanni; Juha Veijola; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2012-11-20       Impact factor: 9.306

3.  Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST).

Authors:  Karin Landolt; Wulf Rössler; Vladeta Ajdacic-Gross; Eske M Derks; Jan Libiger; René S Kahn; W Wolfgang Fleischhacker
Journal:  Schizophr Res       Date:  2016-02-26       Impact factor: 4.939

4.  Five-fold increased risk of relapse following breaks in antipsychotic treatment of first episode psychosis.

Authors:  Toby T Winton-Brown; Thomas Elanjithara; Paddy Power; Ricardo Coentre; Pablo Blanco-Polaina; Philip McGuire
Journal:  Schizophr Res       Date:  2016-10-10       Impact factor: 4.939

5.  The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.

Authors:  Lisa P Henry; G Paul Amminger; Meredith G Harris; Hok Pan Yuen; Susy M Harrigan; Amy L Prosser; Orli S Schwartz; Simone E Farrelly; Helen Herrman; Henry J Jackson; Patrick D McGorry
Journal:  J Clin Psychiatry       Date:  2010-06       Impact factor: 4.384

6.  Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-up.

Authors:  D R Gotfredsen; R S Wils; C Hjorthøj; S F Austin; N Albert; R G Secher; A A E Thorup; O Mors; M Nordentoft
Journal:  Psychol Med       Date:  2017-04-06       Impact factor: 7.723

7.  Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.

Authors:  Meghan Bowtell; Scott Eaton; Kristen Thien; Melissa Bardell-Williams; Linglee Downey; Aswin Ratheesh; Eoin Killackey; Patrick McGorry; Brian O'Donoghue
Journal:  Schizophr Res       Date:  2017-10-21       Impact factor: 4.939

8.  Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up.

Authors:  Stephen F Austin; Ole Mors; Rikke Gry Secher; Carsten R Hjorthøj; Nikolai Albert; Mette Bertelsen; Heidi Jensen; Pia Jeppesen; Lone Petersen; Lasse Randers; Anne Thorup; Merete Nordentoft
Journal:  Schizophr Res       Date:  2013-08-08       Impact factor: 4.939

9.  Identification of psychopathological course trajectories in schizophrenia.

Authors:  Markus Jäger; Prisca Weiser; Thomas Becker; Karel Frasch; Gerhard Längle; Daniela Croissant; Tilman Steinert; Susanne Jaeger; Reinhold Kilian
Journal:  Psychiatry Res       Date:  2013-12-07       Impact factor: 3.222

Review 10.  Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies.

Authors:  John Lally; Olesya Ajnakina; Brendon Stubbs; Michael Cullinane; Kieran C Murphy; Fiona Gaughran; Robin M Murray
Journal:  Br J Psychiatry       Date:  2017-10-05       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.